You can read about our project results in our Results in Brief feature here.
You can submit abstracts now for the 49th Congress of the International Society of Paediatric Oncology, to be held 12 – 15 Oct 2017 in Washington, DC. The deadline is 28 March 2017.
The SIPO congress coincides with the annual Childhood Cancer International (CCI) Congress.
Our publication ‘Fertility preservation in children, adolescents, and young adults with cancer: Quality of clinical practice guidelines and variations in recommendations’ has been published in Cancer (2016 Jul 15;122(14):2216-23. doi: 10.1002/cncr.30047.).
You can read the full, open access article here.
On 03 Mar 2016, PanCareLIFE researcher Prof. Antoinette am Zehnhoff-Dinnesen participated in the World Hearing Day seminar on Childhood hearing loss: act now; here is how! at the WHO headquarters in
Geneva, Switzerland. The event was organized by Professor Alarcos Cieza, Coordinator Blindness and Deafness Prevention, Disability and Rehabilitation (BDD), WHO, and Professor Shelly Chadha, Technical Officer, Prevention of Deafness and Hearing Loss, Blindness and Deafness Prevention, Disability and Rehabilitation, WHO.
It was a great honour for me to make the acquaintance of many highly dedicated personalities from all over the world supporting the interests of deaf and hearing impaired people. In this year the World Hearing Day was dedicated to hearing loss in childhood. In the brilliant brochure “CHILDHOOD HEARING LOSS ACT NOW, HERE’S HOW!” (www.who.int/pbd/deafness/world-hearing-day/en) the WHO highlights the importance of prevention: main causes of hearing loss in childhood include “conditions at the time of birth, infections, diseases of the ear, noise and medicines” and WHO “estimates that around 60% of childhood hearing loss could be avoided through prevention measures”!
Also, Professor Chadha mentioned ototoxicity in her lecture on topics which should be concerned in the future. In addition to the seminar, I had the opportunity to participate in an informal session to discuss possible topics for the prevention of deafness and hearing loss and I stressed the importance of ototoxicity, especially by chemotherapy with Platinum compounds but also in preterm children by aminoglycosides and diuretics, and after application of antimalarial medicaments and HIV/AIDS therapy.
I had the opportunity to hand PanCareLIFE brochures to Alarcos Cieza and Shelly Chadha. Professor Cieza and Professor Chadha who are doing excellent work for deaf and hearing impaired people were interested in the aims of the PanCareLIFE project and appreciated the support by the EU to investigate risk factors in drug metabolism and clinical confounders as basis for preventive measures.
I would be very grateful for further contacts concerning the topic ototoxicity.
Prof. Antoinette am Zehnhoff-Dinnesen
From left to right: Prof. Antoinette am Zehnhoff-Dinnesen, president of UEP and Secretary General of WVC Prof. Shelly Chadha, Technical Officer, Prevention of Deafness and Hearing Loss, Blindness and Deafness Prevention, Disability and Rehabilitation Prof. Katrin Neumann, WHO advisor of WVC Prof. Alarcos Cieza, Coordinator Blindness and Deafness Prevention, Disability and Rehabilitation (BDD), WHO
On 13 Feb 2016, representatives from PanCareLIFE partner FNM will participate in a national childhood oncology day. You can learn more here.
The Danish Cancer Society Research Center, project partner in PanCareLIFE, have recently published the first large-scale study of the lifetime risk for autoimmune diseases after childhood cancer, with risk estimates for a broad range of well-defined, medically verified autoimmune diseases. in Annals of the Rheumatic Diseases (Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS) – Ann Rheum Dis. 2015 Nov 10. pii: annrheumdis-2015-207659).
You can read the press release here.
The first author Anna S. Holmqvist, MD, PhD from Lund in Sweden has also been interviewed for a news story in The Lancet Oncology.
See our Publications page for other PanCareLIFE related publications.
AMC researcher Anna Font-Gonzalez and EMC researcher Eva Clemens, bothInternational Society of Paediatric Oncology (SIOP) Young Investigators, attended the SIOP 2015 meeting in Cape Town.
Anna presented PanCareLIFE at the Young Investigators Educational Day (08 October, below), including an overview of the project and the work done so far on fertility preservation guideline development. It was the first time that the SIOP conference included a programme of sessions aimed at young investigators working in paediatric oncology and this was organized by the SIOP Young Investigators Commitee (SIOPYI-NET), where Anna is a board member.These sessions included lectures at the Educational Day, an Expert Lunch with 6 experts in pediatric oncology and the Junior Investigator Collaborative Event funded by the Texas Children’s Cancer and Hematology Centers, which was attended by 100 young investigators. As the feedback of all these sessions was very positive by both the SIOP Board and the attendees, SIOPYI-NET is already planning young investigators sessions at next year’s SIOP conference that will take place in Dublin (October 2016).
Anna also presented an eposter on 09 October presenting progress on the fertility preservation guidelines.
At the same meeting, Eva was presented with a Young Investigator Award for her abstract entitled: “The influence of co-medication on platinum-related ototoxicity in long-term survivors of childhood cancer: an observational DCOG study”.
PanCare colleague Prof. Beck, University of Erlangen, gave a talk ‘Das Leben nach einer Krebserkrankung von Kindern und Jugendlichen – deutsche und europäische Erfahrungen (Life After Cancer for Children and Adolescents – German and European Experiences)’ at the annual meeting of DGKJ (Deutsche Gesellschaft für Kinder und Jugendmedizin) in Munich, September 2015.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602030. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.